Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2015

Cosentyx(Secukinumab)Novartis AG logoNVS

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Novartis AG

$1.1M

Medicare cost, 2024

Medicare drug plans spent $1.1 million on Cosentyx (secukinumab) in 2024, for 258 prescriptions and refills filled by 60 patients. At about $4,393 per prescription it is a high-cost drug. California accounts for the most spending ($334,837, 30% of the total). It is made by Novartis AG (NVS).

Medicare cost, 2024

$1.1M

Prescriptions

258

$4,393.48 per claim

Patients

60

45 prescribers

Total spending, 2024

$1.1M

$18,891.98 per patient

Questions and answers

How much does Medicare spend on Cosentyx?

Medicare prescription drug plans paid $1.1M for Cosentyx in 2024, for 258 prescriptions and refills to 60 patients. The average cost per claim was $4,393.48.

Which state spends the most on Cosentyx?

California had the highest Medicare cost for Cosentyx in 2024: $335K for 76 claims, followed by Texas ($176K).

Who prescribes Cosentyx the most?

Samy K Metyas, rheumatology in Covina, CA, had the highest Medicare cost for Cosentyx in 2024: 41 claims costing $155K.

Who makes Cosentyx?

Cosentyx is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Cosentyx, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Samy K Metyas Covina, CARheumatology41Under 11$155K
Elvin R Garcia McAllen, TXRheumatology26Under 11$121K
Carolyn B Pace Tempe, AZRheumatology28Under 11$110K
Ramon Moreda Coral Gables, FLRheumatology14Under 11$46K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20244525860$1.1M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
NovartisNVS logoNVS258$1.1M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
9
RxNorm concept IDs
1599792, 1599797, 1653241, 1653243, 2550712
Application numbers
BLA125504, BLA761349

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube